Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

细胞间相互作用定义了维持胎膜稳态的细胞迁移和转变

基本信息

  • 批准号:
    10356919
  • 负责人:
  • 金额:
    $ 43.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-12 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Fetal membranes (amniochorion) protect the fetus during pregnancy. At term, senescence (aging) and inflammation cause functional and mechanical instability to membrane cells, contributing to parturition. Premature senescence and membrane dysfunctions are associated with preterm birth (PTB) and preterm premature rupture of the membranes (pPROM). However, cellular-level changes contributing to membrane stability during gestation and its dysfunction leading to labor and delivery are still unclear. Recent studies of senescent term and preterm membranes revealed “microfractures” (MFs), sites of cellular remodeling. MFs are resealed during gestation to maintain membrane integrity. Higher numbers of MFs and their increased morphometry (depth and width) in term labor, pPROM, and PTB membranes compared to respective controls suggest MFs' resealing is compromised. Amnion epithelial cells in MFs have been observed undergoing epithelial mesenchymal transition (EMT). Further, these cells showed proliferative and resealing properties of deepithelialized (nude/cell free) areas to stabilize membranes. At the healing edge of MFs, amnion mesenchymal cells exhibited a reverse phenomenon, mesenchymal-epithelial transition (MET). From these findings, we postulate that cellular transitions are essential for maintaining fetal membrane integrity. We hypothesize that MFs are areas of membrane remodeling and their increased number and morphometry are associated with failure to remodel and dysfunctional membranes. Understanding intercellular and cell-matrix interactions causing MFs' development and their resealing will help us to determine how oxidative stress (OS) and inflammation can contribute to the persistence of MFs and dysfunctional membrane status in PTB and pPROM. Two specific aims to be tested are Specific Aim 1: To investigate the dynamic remodeling of the fetal membrane epithelium in an in vitro model of cell-free (nude) membranes during OS and infection / inflammation compared to normal conditions; Specific Aim 2: To determine cell migration, matrix degradation, and cellular transition associated with MFs' formation using a fetal membrane organ-on-a-chip approach. This multidisciplinary proposal combines cell and molecular biological and bioengineering approaches designed to overcome the limitations of classic 2D cell cultures by developing a fetal membrane-on-a-chip using organ-on-chip technologies. This model system will maintain multiple cell types in close proximity with constant dynamic interactions, similar to the conditions in utero. We will elucidate causative molecular mechanisms of (normal and abnormal) biologic MFs' formation and how they contribute to PTB and pPROM. Understanding cellular-level mechanisms will allow us to design strategies to minimize MFs' development to strengthen intrauterine cavities and reduce the risk of PTB and pPROM.
胎儿膜(羊膜变量)在怀孕期间保护胎儿。术语,感应(衰老)和炎症会导致膜细胞的功能和机械不稳定性,从而导致分娩。过早的感应和膜功能障碍与早产(PTB)和膜早产相关(PPROM)。然而,在妊娠期间导致膜稳定性的细胞水平变化及其功能障碍导致劳动和分娩尚不清楚。最新对感觉学期和早产膜的研究表明,“微裂缝”(MFS),细胞重塑的位点。在妊娠期间,将MFS重新分配以保持膜完整性。与相对对照相比,较高的MF数量及其在术语,PPROM和PTB膜上的形态计量学(深度和宽度)的增加表明MFS的重新密封受到损害。已经观察到经过上皮间质转变(EMT)的MF中的羊膜上皮细胞。此外,这些细胞显示出深层化(无裸细胞)区域的增殖和重新密封特性,以稳定膜。在MFS的愈合边缘,羊膜间充质细胞暴露了反向现象,间质上皮过渡(MET)。从这些发现中,我们假设细胞过渡对于维持胎儿膜完整性至关重要。我们 假设MFS是膜重塑的区域,其数量和形态计量学的增加与未能重塑和功能障碍膜有关。了解细胞间和细胞矩阵 导致MFS发育及其重新密封的相互作用将有助于我们确定氧化压力(OS)如何 炎症可能有助于PTB和PPROM中MFS和功能失调的膜状态的持久性。要测试的两个具体目的是特定的目标1:与正常情况相比,在OS和感染 /感染期间,在OS和感染 /感染过程中,胎膜上皮的动态重塑与无细胞(裸)膜的体外模型进行了动态重塑;特定目的2:确定使用胎儿膜器官芯片方法的细胞迁移,基质降解和与MFS形成相关的细胞转变。该多学科建议结合了细胞和分子生物学和生物工程学方法,旨在通过使用芯片上的器官芯片技术开发胎儿膜,以克服经典2D细胞培养物的局限性。该模型系统将与恒定的动态相互作用保持多种细胞类型,类似于子宫内的条件。我们将阐明(正常和异常)生物学MFS的形成以及它们如何对PTB和PPROM的贡献。了解细胞水平的机制将使我们能够设计策略,以最大程度地减少MFS的发育,以增强宫内腔内的空腔并降低PTB和PPROM的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arum Han其他文献

Arum Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arum Han', 18)}}的其他基金

3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth
3D 生物制造胎儿-母体界面组织模型,用于确定妊娠期间的药物疗效,以降低早产风险
  • 批准号:
    10438407
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    10349753
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth
3D 生物制造胎儿-母体界面组织模型,用于确定妊娠期间的药物疗效,以降低早产风险
  • 批准号:
    10670735
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    10707445
  • 财政年份:
    2022
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10434794
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Administrative Supplement to Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis
细胞间相互作用的行政补充定义了维持胎膜稳态的细胞迁移和转变
  • 批准号:
    10177264
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening Technology
利用功能性抗体筛选技术加速中和互补位的发现
  • 批准号:
    10088379
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10037855
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip
通过使用芯片上的母胎界面开发基于细胞外囊泡的早产疗法
  • 批准号:
    10492233
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis
细胞间相互作用定义了维持胎膜稳态的细胞迁移和转变
  • 批准号:
    10571858
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:

相似国自然基金

妊娠糖尿病母体羊水和母乳低聚糖组成对后代发育及远期健康的影响及其机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
羊水间充质干细胞增殖新基因Abca4及其下游调控分子在优化干细胞体外扩增与治疗方面应用的研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
羊水间充质干细胞增殖新基因Abca4及其下游调控分子在优化干细胞体外扩增与治疗方面应用的研究
  • 批准号:
    32100640
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
妊娠糖尿病母体羊水和母乳低聚糖组成对后代发育及远期健康的影响及其机制研究
  • 批准号:
    82173500
  • 批准年份:
    2021
  • 资助金额:
    55.00 万元
  • 项目类别:
    面上项目
未足月胎膜早破患者羊水来源的外泌体对羊膜上皮细胞的功能调控及作用机制研究
  • 批准号:
    82001585
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis
细胞间相互作用定义了维持胎膜稳态的细胞迁移和转变
  • 批准号:
    10571858
  • 财政年份:
    2020
  • 资助金额:
    $ 43.99万
  • 项目类别:
Fetal Cell Senescence Signals Initiation of Parturition
胎儿细胞衰老标志着分娩的开始
  • 批准号:
    9276045
  • 财政年份:
    2016
  • 资助金额:
    $ 43.99万
  • 项目类别:
Fetal Cell Senescence Signals Initiation of Parturition
胎儿细胞衰老标志着分娩的开始
  • 批准号:
    9901548
  • 财政年份:
    2016
  • 资助金额:
    $ 43.99万
  • 项目类别:
Fetal Cell Senescence Signals Initiation of Parturition
胎儿细胞衰老标志着分娩的开始
  • 批准号:
    9454525
  • 财政年份:
    2016
  • 资助金额:
    $ 43.99万
  • 项目类别:
RESEARCH ON SCOPE & CAUSES OF STILLBIRTH IN THE US
范围研究
  • 批准号:
    7284368
  • 财政年份:
    2003
  • 资助金额:
    $ 43.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了